Alzheimer

Benzodiazepines and Alzheimer’s: The Lingering Question of Memory Loss

Bélinda Ibrahim, 13/11 10:30 - Reading : 4 minute(s)

Benzodiazepines Alzheimer Memory Anxiety Science Medicine

In the dim aisles of pharmacies, small boxes of benzodiazepines change hands almost furtively, daily companions for millions of people living with anxiety, insomnia, or age-related fragility. Sedatives, anxiolytics, and muscle relaxants, they calm restless minds, ease worry, and help induce sleep. Yet for over a decade, unease has grown: could ...

Europe’s First Alzheimer’s Treatment: Will Leqembi Live Up to Expectations?

Bélinda Ibrahim, 02/10 11:00 - Reading : 3 minute(s)

Alzheimer Treatment Leqembi Europe Science

After decades of research and broken promises, the arrival of Leqembi (lecanemab) marks a symbolic milestone in the fight against Alzheimer’s. Developed by Eisai and Biogen, this monoclonal antibody has just been approved in the European Union for the treatment of early-stage Alzheimer’s. For the first time, a drug aims to slow the progression ...

When AI Confronts Alzheimer’s: Bill Gates’ Million-Dollar Bet

Bélinda Ibrahim, 04/09 13:00 - Reading : 3 minute(s)

Alzheimer Research Bill Gates AI Reward

Is the fight against Alzheimer’s on the brink of a revolution? Driven by Gates, a new international science prize worth $1 million has just been unveiled to encourage the use of AI in tackling this neurodegenerative disease, which currently affects more than 55 million people worldwide. The announcement, made through the Alzheimer’s Disease ...

US Approves First Blood Test for Alzheimer's

This is Beirut, 19/05 12:55 - Reading : 2 minute(s)

Alzheimer United States

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease. The test, developed by Fujirebio Diagnostics, measures the ratio of two proteins in the blood. The rato is correlated with ...

Alzheimer's: A Major Scientific Breakthrough Thanks to Molecular Chaperones

Karl Hajj Moussa, 29/03 11:00 - Reading : 2 minute(s)

Alzheimer Study Proteostasis

Recent research on Alzheimer’s disease suggests that molecular chaperones could play a key role in restoring protein balance in the brain. This innovative approach could improve memory and slow the progression of the disease. Alzheimer’s disease disrupts brain function, leading to memory loss and difficulties with daily tasks. It is ...

Search
Latest news